US 6974820 which cites US 3480626 and “[On azoniaspire-compounds. 2. Preparation of esterified azoniaspire-compounds of nortropan-3-alpha- or 3-beta-ol (1)]”. Arzneimittelforschung17 (6): 719–26. (1967). PMID5632538.
doi.org
“Trospium chloride treatment of overactive bladder”. Ann Pharmacother43 (2): 283–95. (February 2009). doi:10.1345/aph.1L160. PMID19193592.
espacenet.com
worldwide.espacenet.com
DE patent 1194422, Bertholdt H, Pfleger R, Schulz W, "[Verfahren zur Herstellung von Azoniaspironortropanderivaten] (A process for preparing azonia-spirono-tropane derivatives)", issued 1965-06-10, assigned to Dr. Robert Pfleger Chemische Fabrik GmbH
fda.gov
accessdata.fda.gov
FDA “Trospium chloride label”. U.S. Food and Drug Administration (January 2011). 2023年12月17日閲覧。
“Trospium chloride treatment of overactive bladder”. Ann Pharmacother43 (2): 283–95. (February 2009). doi:10.1345/aph.1L160. PMID19193592.
US 6974820 which cites US 3480626 and “[On azoniaspire-compounds. 2. Preparation of esterified azoniaspire-compounds of nortropan-3-alpha- or 3-beta-ol (1)]”. Arzneimittelforschung17 (6): 719–26. (1967). PMID5632538.
